These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 23441126

  • 21. [Intervention of rukangyin on the lymphangiogenesis in breast cancer metastasis nude spontaneous mouse model].
    Li XQ, Dang XG.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Dec; 31(12):1657-61. PubMed ID: 22384554
    [Abstract] [Full Text] [Related]

  • 22. Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3.
    Xu Y, Yuan L, Mak J, Pardanaud L, Caunt M, Kasman I, Larrivée B, Del Toro R, Suchting S, Medvinsky A, Silva J, Yang J, Thomas JL, Koch AW, Alitalo K, Eichmann A, Bagri A.
    J Cell Biol; 2010 Jan 11; 188(1):115-30. PubMed ID: 20065093
    [Abstract] [Full Text] [Related]

  • 23. Foretinib inhibits angiogenesis, lymphangiogenesis and tumor growth of pancreatic cancer in vivo by decreasing VEGFR-2/3 and TIE-2 signaling.
    Chen HM, Tsai CH, Hung WC.
    Oncotarget; 2015 Jun 20; 6(17):14940-52. PubMed ID: 25909285
    [Abstract] [Full Text] [Related]

  • 24. Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2.
    Roberts N, Kloos B, Cassella M, Podgrabinska S, Persaud K, Wu Y, Pytowski B, Skobe M.
    Cancer Res; 2006 Mar 01; 66(5):2650-7. PubMed ID: 16510584
    [Abstract] [Full Text] [Related]

  • 25. Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model.
    Maehana S, Nakamura M, Ogawa F, Imai R, Murakami R, Kojima F, Majima M, Kitasato H.
    Biomed Pharmacother; 2016 Dec 01; 84():660-665. PubMed ID: 27697638
    [Abstract] [Full Text] [Related]

  • 26. Interaction of tumor cells and lymphatic vessels in cancer progression.
    Alitalo A, Detmar M.
    Oncogene; 2012 Oct 18; 31(42):4499-508. PubMed ID: 22179834
    [Abstract] [Full Text] [Related]

  • 27. Angiogenic and lymphangiogenic cascades in the tumor microenvironment.
    Onimaru M, Yonemitsu Y.
    Front Biosci (Schol Ed); 2011 Jan 01; 3(1):216-25. PubMed ID: 21196371
    [Abstract] [Full Text] [Related]

  • 28. A novel role for ezrin in breast cancer angio/lymphangiogenesis.
    Ghaffari A, Hoskin V, Szeto A, Hum M, Liaghati N, Nakatsu K, LeBrun D, Madarnas Y, Sengupta S, Elliott BE.
    Breast Cancer Res; 2014 Sep 18; 16(5):438. PubMed ID: 25231728
    [Abstract] [Full Text] [Related]

  • 29. Blocking neuropilin-2 function inhibits tumor cell metastasis.
    Caunt M, Mak J, Liang WC, Stawicki S, Pan Q, Tong RK, Kowalski J, Ho C, Reslan HB, Ross J, Berry L, Kasman I, Zlot C, Cheng Z, Le Couter J, Filvaroff EH, Plowman G, Peale F, French D, Carano R, Koch AW, Wu Y, Watts RJ, Tessier-Lavigne M, Bagri A.
    Cancer Cell; 2008 Apr 18; 13(4):331-42. PubMed ID: 18394556
    [Abstract] [Full Text] [Related]

  • 30. VEGF-C and VEGF-C156S in the pro-lymphangiogenic growth factor therapy of lymphedema: a large animal study.
    Visuri MT, Honkonen KM, Hartiala P, Tervala TV, Halonen PJ, Junkkari H, Knuutinen N, Ylä-Herttuala S, Alitalo KK, Saarikko AM.
    Angiogenesis; 2015 Jul 18; 18(3):313-26. PubMed ID: 26018927
    [Abstract] [Full Text] [Related]

  • 31. Tumor-induced lymphangiogenesis in cervical lymph nodes in oral melanoma-bearing mice.
    Ozasa R, Ohno J, Iwahashi T, Taniguchi K.
    J Exp Clin Cancer Res; 2012 Oct 02; 31(1):83. PubMed ID: 23031500
    [Abstract] [Full Text] [Related]

  • 32. Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis.
    Burton JB, Priceman SJ, Sung JL, Brakenhielm E, An DS, Pytowski B, Alitalo K, Wu L.
    Cancer Res; 2008 Oct 01; 68(19):7828-37. PubMed ID: 18829538
    [Abstract] [Full Text] [Related]

  • 33. The angiostatic protein 16K human prolactin significantly prevents tumor-induced lymphangiogenesis by affecting lymphatic endothelial cells.
    Kinet V, Castermans K, Herkenne S, Maillard C, Blacher S, Lion M, Noël A, Martial JA, Struman I.
    Endocrinology; 2011 Nov 01; 152(11):4062-71. PubMed ID: 21862622
    [Abstract] [Full Text] [Related]

  • 34. Vascular endothelial growth factor (VEGF)-C, VEGF-D, VEGFR-3 and D2-40 expressions in primary breast cancer: Association with lymph node metastasis.
    Eroğlu A, Ersöz C, Karasoy D, Sak S.
    Adv Clin Exp Med; 2017 Nov 01; 26(2):245-249. PubMed ID: 28791841
    [Abstract] [Full Text] [Related]

  • 35. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.
    He Y, Kozaki K, Karpanen T, Koshikawa K, Yla-Herttuala S, Takahashi T, Alitalo K.
    J Natl Cancer Inst; 2002 Jun 05; 94(11):819-25. PubMed ID: 12048269
    [Abstract] [Full Text] [Related]

  • 36. Distinct architecture of lymphatic vessels induced by chimeric vascular endothelial growth factor-C/vascular endothelial growth factor heparin-binding domain fusion proteins.
    Tammela T, He Y, Lyytikkä J, Jeltsch M, Markkanen J, Pajusola K, Ylä-Herttuala S, Alitalo K.
    Circ Res; 2007 May 25; 100(10):1468-75. PubMed ID: 17478733
    [Abstract] [Full Text] [Related]

  • 37. Expression of vascular endothelial growth factor-C and its receptor in invasive micropapillary carcinoma of the breast.
    Li YS, Kaneko M, Amatya VJ, Takeshima Y, Arihiro K, Inai K.
    Pathol Int; 2006 May 25; 56(5):256-61. PubMed ID: 16669874
    [Abstract] [Full Text] [Related]

  • 38. Comparison of molecular determinants of angiogenesis and lymphangiogenesis in lymph node metastases and in primary tumours of patients with breast cancer.
    Van den Eynden GG, Van der Auwera I, Van Laere SJ, Trinh XB, Colpaert CG, van Dam P, Dirix LY, Vermeulen PB, Van Marck EA.
    J Pathol; 2007 Sep 25; 213(1):56-64. PubMed ID: 17674348
    [Abstract] [Full Text] [Related]

  • 39. Endothelial nitric oxide synthase mediates lymphangiogenesis and lymphatic metastasis.
    Lahdenranta J, Hagendoorn J, Padera TP, Hoshida T, Nelson G, Kashiwagi S, Jain RK, Fukumura D.
    Cancer Res; 2009 Apr 01; 69(7):2801-8. PubMed ID: 19318557
    [Abstract] [Full Text] [Related]

  • 40. CPT1A regulates breast cancer-associated lymphangiogenesis via VEGF signaling.
    Xiong Y, Liu Z, Zhao X, Ruan S, Zhang X, Wang S, Huang T.
    Biomed Pharmacother; 2018 Oct 01; 106():1-7. PubMed ID: 29940537
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.